VeridianLabs Research Publishing Partner Programme
We work with publishers and educators whose audiences engage with laboratory methods, analytical chemistry, biotechnology education and research-industry information.
VeridianLabs products are supplied solely for laboratory and analytical research. They are not medicines, food supplements or cosmetics and are not for human or veterinary use.
Why partner with VeridianLabs?
- Access to factual product specifications and batch documentation where available.
- Educational resources covering analytical testing, laboratory handling and research-supply evaluation.
- Transparent partner terms and trackable referrals.
- Direct support for questions about permitted factual claims and current testing status.
How it works
- Apply with details of your publication, channel or educational project.
- We review audience relevance, scientific accuracy and compliance approach.
- Approved partners receive a referral link and access to current factual resources.
- Eligible referrals are recorded under the programme terms.
Programme terms
| Commission | 20% on the net value of every qualifying sale |
|---|---|
| Tracking period | 30 days |
| Payment schedule | Monthly, by the 15th of the following month |
| Minimum payout | £50 |
| Approval | Applications are reviewed manually |
Who the programme is for
- Science communicators
- Research educators
- Laboratory and research-method publishers
- Analytical chemistry and biotechnology educators
- Research-industry publications
- Educational channels covering quality assurance, chromatography, mass spectrometry or laboratory practice
Publishing standards
Partners must describe products accurately as Research Use Only and must use only verified specifications and testing statements. Content must not:
- present products as medicines, supplements, cosmetics or consumer wellness products;
- claim treatment, recovery, appearance, performance or other outcomes in people or animals;
- provide administration guidance;
- imply that preclinical observations establish human benefit;
- state that testing or a COA exists unless that status is confirmed for the relevant batch.
Published scientific findings may be discussed neutrally when the model, evidence limits and preclinical or in-vitro context are made clear.
Apply
Use our partner application and include a link to the publication or educational channel you intend to use.
Participation does not authorise medical, therapeutic or human-use promotion. VeridianLabs may decline or end participation where content conflicts with the stated Research Use Only model.
